SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The Impact of Differences in EQ-5D and SF-6D Utility Scores on the Acceptability of Cost–Utility Ratios: Results across Five Trial-Based Cost–Utility Studies
16 references·0 citing·36 second hop
The Impact of Differences in EQ-5D and SF-6D Utility Scores on the Acceptability of Cost–Utility Ratios: Results across Five Trial-Based Cost–Utility Studies (2009)The Impact of Differences in EQ-5D and SF…SF-36 Health Survey. (2008)SF-36 Health Survey.Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease. (2006)Comparison of the SF-6D and t…Comparing the EQ-5D and the SF-6D Descriptive Systems to Assess Their Ceiling Effects in the US General Population (2006)Comparing the EQ-5D and the S…Estimating mean QALYs in trial‐based cost‐effectiveness analysis: the importance of controlling for baseline utility (2004)Estimating mean QALYs in tria…A comparison of the EQ‐5D and SF‐6D across seven patient groups (2004)A comparison of the EQ‐5D and…A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis (2004)A comparison of generic, indi…A Comparison of Four Indirect Methods of Assessing Utility Values in Rheumatoid Arthritis (2004)A Comparison of Four Indirect…SF-36 health survey: Manual and interpretation guide (2003)SF-36 health survey: Manual a…An empirical comparison of EQ‐5D and SF‐6D in liver transplant patients (2003)An empirical comparison of EQ…The estimation of a preference-based measure of health from the SF-36 (2002)The estimation of a preferenc…Deriving a Preference-Based Single Index from the UK SF-36 Health Survey (1998)Deriving a Preference-Based S…Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation (1997)Pulling cost-effectiveness an…Modeling Valuations for EuroQol Health States (1997)Modeling Valuations for EuroQ…Valuing health states: A comparison of methods (1996)Valuing health states: A comp…Costs, effects and C/E‐ratios alongside a clinical trial (1994)Costs, effects and C/E‐ratios…EuroQol - a new facility for the measurement of health-related quality of life (1990)EuroQol - a new facility for …A Guide to Simulation (1983)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Handling Uncertainty in Cost-Effectiveness Models (2000)Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions (2004)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments (2001)Estimating an EQ‐5D population value set: the case of Japan (2002)Methods for the Economic Evaluation of Health Care Programmes (2005)South Korean Time Trade-Off Values for EQ-5D Health States: Modeling with Observed Values for 101 Health States (2009)The magical number seven, plus or minus two: Some limits on our capacity for processing information. (1956)The magical number seven, plus or minus two: Some limits on our capacity for processing information. (1994)Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force (2013)Health, Health-Related Quality of Life, and Quality of Life: What is the Difference? (2016)The MOS 36-ltem Short-Form Health Survey (SF-36) (1992)A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures (2009)Adult measures of general health and health‐related quality of life: Medical Outcomes Study Short Form 36‐Item (SF‐36) and Short Form 12‐Item (SF‐12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF‐6D), Health Utilities Index Mark 3 (HUI3), Quality of Well‐Being Scale (QWB), and Assessment of Quality of Life (AQ O L) (2011)Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey (2014)Cost-Effectiveness in Health and Medicine (1996)Representing uncertainty: the role of cost‐effectiveness acceptability curves (2001)How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study (2003)Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting (2011)Microsimulation Modeling for Health Decision Sciences Using R: A Tutorial (2018)The MOS 36-ltem Short-Form Health Survey (SF-36): III. Tests of Data Quality, Scaling Assumptions, and Reliability Across Diverse Patient Groups (1994)A 12-Item Short-Form Health Survey (1996)The Brief Illness Perception Questionnaire (2006)Psychometric and Clinical Tests of Validity of the Japanese SF-36 Health Survey (1998)The French SF-36 Health Survey (1998)Intervention studies to foster resilience – A systematic review and proposal for a resilience framework in future intervention studies (2017)Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets (2012)Valuing health-related quality of life: An EQ-5D-5L value set for England (2017)Handling uncertainty when performing economic evaluation of healthcare interventions. (1999)Decision Making in Health and Medicine: Integrating Evidence and Values (2001)Thinking Outside the Box: Recent Advances in the Analysis and Presentation of Uncertainty in Cost-Effectiveness Studies (2002)EuroQol: the current state of play (1996)EQ-SD: a measure of health status from the EuroQol Group (2001)
this work references cited by second hop

References

  • 1990EuroQol - a new facility for the measurement of health-related quality of life15,736 cited
  • 2003SF-36 health survey: Manual and interpretation guide11,424 cited
  • 1997Modeling Valuations for EuroQol Health States4,543 cited
  • 2002The estimation of a preference-based measure of health from the SF-363,031 cited
  • 2004Estimating mean QALYs in trial‐based cost‐effectiveness analysis: the importance of controlling for baseline utility1,023 cited
  • 1994Costs, effects and C/E‐ratios alongside a clinical trial963 cited
  • 2008SF-36 Health Survey.947 cited
  • 1997Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation883 cited
  • 2004A comparison of the EQ‐5D and SF‐6D across seven patient groups797 cited
  • 1998Deriving a Preference-Based Single Index from the UK SF-36 Health Survey686 cited
  • 2004A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis398 cited
  • 1996Valuing health states: A comparison of methods336 cited
  • 2003An empirical comparison of EQ‐5D and SF‐6D in liver transplant patients184 cited
  • 2006Comparing the EQ-5D and the SF-6D Descriptive Systems to Assess Their Ceiling Effects in the US General Population

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

179 cited
  • 2004A Comparison of Four Indirect Methods of Assessing Utility Values in Rheumatoid Arthritis123 cited
  • 2006Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease.122 cited
  • Cited by

    No citing works inside the corpus for this window.